RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CESARO A
Collezione AOU Novara

Items : 9

Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry). in ESC heart failure / ESC Heart Fail. 2025 Jun;12(3):1786-1795. doi: 10.1002/ehf2.15172. Epub 2025 Feb 5.

2025
AOU Novara

Paolillo S; Basile C; Marzano F; Bruzzese D; Agostoni P; Mattavelli I; Aloisio A; Ameri P; Solimano M; Brunetti ND; Calabrò P; Cesaro A; Cameli M; Mandoli GE; Carluccio E; Belardinelli C; Carugo S; Casalino L; Chiuini E; Cosmi D; Dini FL; Di Santo M; Esposito G; Ferrara F; Fierro MF; Galasso G; Gallo L; Rispoli A; Gargiulo P; et alii...

Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry). in Journal of the American College of Cardiology / J Am Coll Cardiol. 2025 Feb 11;85(5):536-540. doi: 10.1016/j.jacc.2024.10.106. Epub 2024 Dec 11.

2025
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Corsini A; Perrone Filardi P; Paolillo S; Esposito G; Perrone Filardi F; Di Santo M; Cotticelli C; Fontanarosa S; Franzese M; Mancusi C; Delnevo F; Varbella F; Cesaro A; Formisano C; Di Costanzo A; Giannattasio C; Sarullo S; Andò G; Di Lorenzo E; Berteotti M; Margonato A; Floresta M; Muscoli S; Cameli M; Patti G; Porto I; Brunetti ND; Pepe M; Montisci R; et alii...

Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry. in European journal of preventive cardiology / Eur J Prev Cardiol. 2024 Nov 11;31(15):1806-1816. doi: 10.1093/eurjpc/zwae170.

2024
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Merolla A; Iannone FP; Romano A; Dell'Anno R; Vallefuoco G; Passaretti G; Testa C; Cuomo G; Perrone-Filardi P; Paolillo S; Soricelli A; Salvatore M; Prastaro M; Nardi E; Parlati ALM; Buonocore D; Indolfi C; Fontanarosa S; Marzano F; Bilato C; Crisci M; Paloscia L; Brunetti ND; Casu G; De Luca L; Merlini PA; Maloberti A; Quarta R; Polimeni A; et alii...

[Multidistrict atherosclerotic disease: epidemiological and clinical framework]. in Giornale italiano di cardiologia (2006) / G Ital Cardiol (Rome). 2024 Apr;25(4):239-251. doi: 10.1714/4244.42205.

2024
AOU Novara

Di Fusco SA; Amico AF; Lucà F; Colivicchi F; Oliva F; Gabrielli D; Grimaldi M; Gulizia MM; Monitillo F; Maloberti A; Fileti L; Lopriore V; Di Martino M; Di Nora C; D'Errigo P; Ciccirillo F; Cocozza S; Cesaro A; Bugani G; Binaghi G; Baccino D; Acerbo V; Altamura V; Temporelli PL; Ceravolo R; Mureddu GF; Abrignani MG;

[New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention]. in Giornale italiano di cardiologia (2006) / G Ital Cardiol (Rome). 2023 Feb;24(2):99-109. doi: 10.1714/3963.39417.

2023
AOU Novara

Gragnano F; Capolongo A; Terracciano F; Gargiulo G; Cesaro A; Moscarella E; De Sio V; Patti G; Porto I; Esposito G; Calabrò P;

Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology. in Vascular pharmacology / Vascul Pharmacol. 2023 Feb;148:107137. doi: 10.1016/j.vph.2022.107137. Epub 2022 Dec 1.

2023
AOU Novara

Patti G; Cavallari I; Cesaro A; Gragnano F; Riva L; Fimiani F; Cuccia C; Fresco C; Calabrò P; Leonardi S; Marcucci R; Rubboli A;

Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease. in Circulation / Circulation. 2021 Oct 19;144(16):1323-1343. doi: 10.1161/CIRCULATIONAHA.121.054305. Epub 2021 Oct 18

2021
AOU Novara

Calabrò P; Gragnano F; Niccoli G; Marcucci R; Zimarino M; Spaccarotella C; Renda G; Patti G; Andò G; Moscarella E; Mancone M; Cesaro A; Giustino G; De Caterina R; Mehran R; Capodanno D; Valgimigli M; Windecker S; Dangas GD; Indolfi C; Angiolillo DJ;

Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry. in Internal and emergency medicine / Intern Emerg Med. 2021 Mar;16(2):379-387. doi: 10.1007/s11739-020-02404-1. Epub 2020 Jun 15.

2021
AOU Novara

Sasso FC; Gaudio C; Pelliccia F; Palareti G; Cirillo P; Pignatelli P; Antonucci E; Cavallari I; Patti G; Ielasi A; Pafundi PC; Cesaro A; Calabrò P; Moscarella E; Gragnano F; Pengo V; Gresele P; Marcucci R;

Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry. in International journal of cardiology / Int J Cardiol. 2021 Dec 15;345:7-13. doi: 10.1016/j.ijcard.2021.10.138. Epub 2021 Oct 23.

2021
AOU Novara

Cesaro A; Gragnano F; Calabrò P; Moscarella E; Santelli F; Fimiani F; Patti G; Cavallari I; Antonucci E; Cirillo P; Pignatelli P; Palareti G; Pelliccia F; Bossone E; Pengo V; Gresele P; Marcucci R;